Pricing Log in Create free account

OSR Health, Inc. (OSRH) vs Nuvilex Inc. (PMCB)

OSR Health, Inc. and Nuvilex Inc. are both Biotechnology companies. OSR Health, Inc. and Nuvilex Inc. are of similar size ($4.1M and $3.8M). OSR Health, Inc. grew revenue faster over the last twelve months: −50.2% against −71.1%. Nuvilex Inc. has the higher net margin (0.00% vs −1,093.4%) and the higher return on invested capital (0.00% vs −8.19%). Across the 15 metrics below, OSR Health, Inc. leads on 8 and Nuvilex Inc. on 7.

Valuation

Metric OSRH PMCB Biotechnology median
P/E n/m n/m 8.50
P/S 4.00 n/m 9.71
P/B 0.06 0.13 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 3.82 0.64
EV/Sales 6.17 n/m 9.21
Earnings yield (168.18%) (679.41%) (33.15%)
Free cash flow yield (105.52%) (290.03%) (25.50%)

Profitability

Metric OSRH PMCB Biotechnology median
Gross margin 35.29% 95.64% 65.16%
Operating margin (933.72%) 0.00% 0.00%
Net margin (1,093.41%) 0.00% 0.00%
Free cash flow margin (398.26%) 0.00% 0.00%
Return on equity (14.98%) (58.04%) (56.36%)
Return on assets (11.24%) (50.43%) (48.04%)
Return on invested capital (8.19%) 0.00% 0.00%

Growth

Metric OSRH PMCB Biotechnology median
Revenue growth (TTM) (50.24%) (71.06%) 6.02%
EPS growth (last fiscal year) 71.07% (186.83%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric OSRH PMCB Biotechnology median
Debt to equity 0.04 0.00 0.00
Current ratio 0.18 40.29 4.72
Net debt to EBITDA (0.29) 5.41 0.96

Dividend

Metric OSRH PMCB Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric OSRH PMCB Biotechnology median
Market cap 4.09m 3.84m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack